บทความที่มีข้อกำหนดการเข้าถึงสาธารณะ - Stella daviesดูข้อมูลเพิ่มเติม
ไม่มีให้ใช้งานในทุกที่: 10
Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults
CL Phillips, SM Davies, R McMasters, M Absalon, M O'Brien, J Mo, ...
British journal of haematology 161 (3), 406-410, 2013
ข้อกำหนด: US National Institutes of Health
Successful early intervention for hyperacute transplant‐associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation
S Jodele, JJ Bleesing, PA Mehta, AH Filipovich, BL Laskin, J Goebel, ...
Pediatric Transplantation 16 (2), E39-E42, 2012
ข้อกำหนด: US National Institutes of Health
Pretransplant genetic susceptibility: clinical relevance in transplant-associated thrombotic microangiopathy
E Gavriilaki, T Touloumenidou, I Sakellari, I Batsis, D Mallouri, ...
Thrombosis and haemostasis 120 (04), 638-646, 2020
ข้อกำหนด: European Hematology Association, Netherlands
Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia
JP Uberti, MA Agovi, S Tarima, M Haagenson, S Gandham, C Anasetti, ...
Bone marrow transplantation 46 (1), 34-43, 2011
ข้อกำหนด: US National Institutes of Health
Hemophagocytic lymphohistiocytosis in a female patient due to a heterozygous XIAP mutation and skewed X chromosome inactivation
JR Holle, RA Marsh, AM Holdcroft, SM Davies, L Wang, K Zhang, ...
Pediatric Blood & Cancer 62 (7), 1288-1290, 2015
ข้อกำหนด: US National Institutes of Health
Predictors of health‐related quality of life over time among pediatric hematopoietic stem cell transplant recipients
KA Loiselle, JR Rausch, S Bidwell, S Drake, SM Davies, ALH Pai
Pediatric blood & cancer 63 (10), 1834-1839, 2016
ข้อกำหนด: US National Institutes of Health
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study
P Khandelwal, T Fukuda, A Teusink-Cross, ADM Kashuba, A Lane, ...
Bone Marrow Transplantation 55 (8), 1552-1559, 2020
ข้อกำหนด: US National Institutes of Health
Severe allergic reactions to thiol-based cytoprotective agents mesna and amifostine in a child with a supratentorial primitive neuroectodermal tumor
K Dorris, M Fouladi, SM Davies, JP Perentesis, JM Lawrence, LML Chow, ...
Journal of Pediatric Hematology/Oncology 33 (6), e250-e252, 2011
ข้อกำหนด: US National Institutes of Health
造血幹細胞移植後長期生存者に推奨されるスクリーニングおよび予防診療
熱田由子， 岡本真一郎
臨床血液 55 (6), 607-632, 2014
ข้อกำหนด: US National Institutes of Health
Psychometric evaluation of the brief RCOPE and relationships with psychological functioning among caregivers of children undergoing hematopoietic stem cell transplant
ME McGrady, CA Mara, K Geiger‐Behm, J Ragsdale, SM Davies, ...
Psycho‐Oncology 30 (9), 1457-1465, 2021
ข้อกำหนด: US National Institutes of Health
มีให้ใช้งานในบางที่: 176
Improved early event-free survival with imatinib in Philadelphia chromosome–positive acute lymphoblastic leukemia: A children's oncology group study
KR Schultz, WP Bowman, A Aledo, WB Slayton, H Sather, M Devidas, ...
Journal of Clinical Oncology 27 (31), 5175-5181, 2009
ข้อกำหนด: US National Institutes of Health
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
NS Majhail, JD Rizzo, SJ Lee, M Aljurf, Y Atsuta, C Bonfim, LJ Burns, ...
Hematology/oncology and stem cell therapy 5 (1), 1-30, 2012
ข้อกำหนด: US National Institutes of Health
The Childhood Cancer Survivor Study: a National Cancer Institute–supported resource for outcome and intervention research
LL Robison, GT Armstrong, JD Boice, EJ Chow, SM Davies, ...
Journal of clinical oncology 27 (14), 2308-2318, 2009
ข้อกำหนด: US National Institutes of Health
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031
KR Schultz, A Carroll, NA Heerema, WP Bowman, A Aledo, WB Slayton, ...
Leukemia 28 (7), 1467-1471, 2014
ข้อกำหนด: US National Institutes of Health
Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase …
AS Gamis, TA Alonzo, S Meshinchi, L Sung, RB Gerbing, SC Raimondi, ...
Journal of Clinical Oncology 32 (27), 3021-3032, 2014
ข้อกำหนด: US National Institutes of Health
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults
S Jodele, SM Davies, A Lane, J Khoury, C Dandoy, J Goebel, K Myers, ...
Blood, The Journal of the American Society of Hematology 124 (4), 645-653, 2014
ข้อกำหนด: US National Institutes of Health
A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury
S Jodele, BL Laskin, CE Dandoy, KC Myers, J El-Bietar, SM Davies, ...
Blood reviews 29 (3), 191-204, 2015
ข้อกำหนด: US National Institutes of Health
Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy
S Jodele, C Licht, J Goebel, BP Dixon, K Zhang, TA Sivakumaran, ...
Blood, The Journal of the American Society of Hematology 122 (12), 2003-2007, 2013
ข้อกำหนด: US National Institutes of Health
Prevalence of hematopoietic cell transplant survivors in the United States
NS Majhail, L Tao, C Bredeson, S Davies, J Dehn, JL Gajewski, T Hahn, ...
Biology of Blood and Marrow Transplantation 19 (10), 1498-1501, 2013
ข้อกำหนด: US National Institutes of Health
Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia
JJ Yang, C Cheng, W Yang, D Pei, X Cao, Y Fan, SB Pounds, G Neale, ...
Jama 301 (4), 393-403, 2009
ข้อกำหนด: US National Institutes of Health
แหล่งที่มาและข้อมูลกองทุนดำเนินการโดยโปรแกรมคอมพิวเตอร์โดยอัตโนมัติ